Management of pregnancies complicated by anti‐kell isoimmunization

Obstetrics and Gynecology

Volumn 93, Issue 5, 1999, Pages 667-673

  MCKENNA, DAVID S ^a   NAGARAJA, H N ^a   O'SHAUGHNESSY, RICHARD ^a  

^a THE OHIO STATE UNIVERSITY COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

RHESUS D ANTIBODY;

AMNION FLUID ANALYSIS; ARTICLE; ERYTHROPOIESIS; FEMALE; HEMOLYSIS; HUMAN; IMMUNIZATION; MAJOR CLINICAL STUDY; PREGNANCY COMPLICATION; PRIORITY JOURNAL; RHESUS ISOIMMUNIZATION;

ADULT; BLOOD GROUP INCOMPATIBILITY; ERYTHROBLASTOSIS, FETAL; FEMALE; HUMANS; INFANT, NEWBORN; ISOANTIBODIES; KELL BLOOD-GROUP SYSTEM; MALE; PREGNANCY; PREGNANCY COMPLICATIONS, HEMATOLOGIC; PRENATAL CARE; PRENATAL DIAGNOSIS; PROGNOSIS;

EID: 0032901946     PISSN: 00297844     EISSN: 1873233X     Source Type: Journal    
DOI: 10.1016/s0029-7844(98)00491-8     Document Type: Article

References (21)

1. Bowman JM. Hemolytic disease (erythroblastosis fetalis). In: Creasy RK, Resnick R, eds. Maternal fetal medicine: Principles and practice. 3rd ed. Philadelphia: WB Saunders, 1994:711-43.
2. Jackson M, Branch DW. Isoimmunization in pregnancy. In: Gabbe SG, Niebyl JR, Simpson JL, eds. Obstetrics: Normal and problem pregnancies. 3rd ed. New York: Churchill Livingstone, 1996:899-932.
3. Weinstein L. Irregular antibodies causing hemolytic disease of the newborn: A continuing problem. Clin Obstet Gynecol 1982;25:321-32.
4. Turner AJ, Tanzawa K. Mammalian membrane metallopeptidases: NEP, ECE, KELL, and PEX. FASEB J 1997;11:355-64.
5. Vaughan JI, Manning M, Warwick RM, Letsky EA, Murray NA, Roberts IAG. Inhibition of erythroid progenitor cells by anti-Kell antibodies in fetal alloimmune anemia. N Engl J Med 1998;338:798-803.
6. Vaughan JI, Warwick R, Letsky E, Nicolini U, Rodeck CH, Fisk NM. Erythropoietic suppression in fetal anemia because of Kell alloimmunization. Am J Obstet Gynecol 1994;171:247-52.
7. Weiner CP, Widness JA. Decreased fetal erythropoiesis and hemolysis in Kell hemolytic anemia. Am J Obstet Gynecol 1996;174:547-51.
8. American Association of Blood Banks. Technical manual of the American Association of Blood Banks. 9th ed. Arlington, Virginia: American Association of Blood Banks, 1985.
9. Liley AW. Liquor amnii analysis in the management of the pregnancy complicated by rhesus sensitization. Am J Obstet Gynecol 1961;82:1359-70.
10. Liley AW. Assessment of hemolytic disease from amniotic fluid. Am J Obstet Gynecol 1963;86:485-94.
11. Sall J, Lehman A. JMP start statistics: A guide to statistics and data analysis using JMP and JMP IN software. 1st ed. Belmont, California: Duxbury Press, 1996:115-47.
12. Frigoletto FD, Davies IJ. Erythroblastosis fetalis with hydrops resulting from anti-Kell isoimmune disease. Am J Obstet Gynecol 1977;127:887.
13. Barss VA, Benacerraf BR, Greene MF, Phillippe M, Frigoletto FD. Sonographic detection of fetal hydrops. A report of two cases. J Reprod Med 1985;30:893-4.
14. Marsh WL, Redman CM. The Kell blood group system: A review. Transfusion 1990;30:158-67.
15. Wenk RE, Goldstein P, Felix JK. Kell alloimmunization, hemolytic disease of the newborn, and perinatal management. Obstet Gynecol 1985;66:473-6.
16. Caine ME, Mueller-Heubach E. Kell sensitization in pregnancy. Am J Obstet Gynecol 1986;154:85-90.
17. Leggat HM, Gibson JM, Barron SL, Reid MM. Anti-Kell in pregnancy. Br J Obstet Gynaecol 1991;98:162-5.
18. Bowman JM, Pollock JM, Manning FA, Harman CR, Menticoglou S. Maternal Kell blood group alloimmunization. Obstet Gynecol 1992;79:239-44.
19. Berkowitz RL, Beyth Y, Sadovsky E. Death in utero due to Kell sensitization without excessive elevation of the delta OD40 value in amniotic fluid. Obstet Gynecol 1982;60:746-9.
20. Lee S, Bennet PR, Overton T, Warwick R, Wu X, Redman C. Prenatal diagnosis of Kell blood group genotypes: KEL1 and KEL2. Am J Obstet Gynecol 1996;175:455-9.
21. Spence WC, Maddalena A, Demers DB, Bick DP. Prenatal determination of genotypes Kell and Cellano in at-risk pregnancies. J Reprod Med 1997;42:353-7.